Listing Page

Category: Bulk Active Ingredient

How the Right CDMO Partner Can Ensure Your Antibody Drug Conjugate Project is a Success
Antibody-drug conjugates (ADC) are one of the fastest-growing anticancer drug segments, linking the targeting...
Read More >
Building a Pharmaceutical API Procurement Strategy that Delivers
In an earlier post, LGM Pharma’s Lina Cogan discussed the difference between the act of Purchasing vs....
Read More >
Niche Active Pharmaceutical Ingredients and How to Source Them
What is one of the most significant trends driving growth in the global API market? It’s the rise of...
Read More >
Patent Cliff 2.0: How to Leverage the 351(k) Pathway for Biosimilars
More than $198 billion in global prescription drug sales are at risk from patent expirations between...
Read More >
Overcoming API Challenges for Novel Drug Delivery Systems
The 505(b)(2) regulatory pathway is an increasingly popular method of getting drug approval – and one...
Read More >